The DOI matches its Crossref record; 91 of the 92 references it cites were found in a registry or an index.
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Abstract
Breast cancer development largely depends upon the essential contributions from the tumor microenvironment, where several inflammatory cell populations (e.g. macrophages) orchestrate breast cancer development. The majority of tumor-associated macrophages (TAMs) exhibit alternatively activated M2 properties, produce abundant anti-inflammatory factors and facilitate tumor development. Clinical evidences compellingly indicate the association between high TAMs influx and poor prognosis in patients with breast cancers. The pan-macrophage marker CD68 is now generally utilized to identify TAMs in diagnostic biopsy samples, and some other TAM-related biomarkers are also utilized in prognosis prediction, including CD163, vascular endothelial growth factor (VEGF), hypoxia-inducible factors (HIFs), proliferating cellular nuclear antigen (PCNA), ferritin light chain (FTL) and C-C motif chemokine ligand 18 (CCL18). In this review, we highlight the recent progress made in understanding the relationship between TAMs and clinicopathological parameters in human breast cancer and address the potential value of TAMs as diagnostic and prognostic biomarkers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the appearance of tumor-supporting, iron-donating immune cells, in particular macrophages, is associated with tumor size and aggressiveness as well as poor patient prognosis [56,57].”
From Iron as a central player and promising target in cancer progression (2019) · cites this paper as [56]
Citations
Cites
1 retracted
Yamamoto, N., Suyama, H., Yamamoto, N., & Ushijima, N. (2007) · International Journal of Cancer · doi:10.1002/ijc.23107 · Cited by 62
RetractedExploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L. D., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,456
Breast cancer statistics, 2013
Desantis, C. E., Ma, J., Bryan, L. N., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21203 · Cited by 2,142
Ma, J., & Jemal, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,918
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Flagged first, then by citations
1 of the 92 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Laoui, 2011, Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions, Int. J. Dev. Biol., 55, 861, 10.1387/ijdb.113371dl · DOI
Cited by
Sorted by citations
Items 201–276 of 276
Salmaninejad, A., Layeghi, S. M., Falakian, Z., Foroushani, P. S., Golestani, S., Pourghazi, F., Kobravi, S., & Yousefi, M. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02055-0 · Cited by 9
Gao, X., Yang, H., Chu, Y., Zhang, W., Wang, Z., & Ji, L. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106385 · Cited by 8
Saito, H., Shimizu, S., Kono, Y., Murakami, Y., Shishido, Y., Miyatani, K., Matsunaga, T., Fukumoto, Y., Ashida, K., & Fujiwara, Y. (2019) · Surgery Today · doi:10.1007/s00595-019-01817-6 · Cited by 8
Beyond Promoter: The Role of Macrophage in Invasion and Progression of Renal Cell Carcinoma
Zhang, H., & Zhu, G. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200225093210 · Cited by 8
Çalık, M., Çalık, İ., Artaş, G., & Özercan, İ. H. (2021) · Gastroenterology Research and Practice · doi:10.1155/2021/7249726 · Cited by 8
Guellec, S. L., Duprez-Paumier, R., & Lacroix‐Triki, M. (2014) · médecine/sciences · doi:10.1051/medsci/20143004009 · Cited by 7
Wilson, A., Garmo, L. C., & Podgorski, I. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108274 · Cited by 7
Zhang, N., Li, C., Zhao, Z., Jiang, B., Wang, W., Sun, F., Zhang, Y., & Zhu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1497004 · Cited by 8
Fadhil, M., Abdul‐Rasheed, O. F., & AL-Naqqash, M. A. M. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2019_2855 · Cited by 7
Takei, J., Tanaka, T., Teshigawara, A., Tochigi, S., Hasegawa, Y., & Murayama, Y. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-1896 · Cited by 7
Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer
Raphael, J., Gong, I. Y., Nofech‐Mozes, S., Bartlett, J., Nafisi, H., & Verma, S. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203493 · Cited by 7
Zhang, Y., LIM, D. J., Cai, Z., Peng, J., Jia, B., Chu, G., Zhang, F., Dong, C., & Feng, Z. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113779 · Cited by 6
Expression Profile of Inflammatory Breast Cancer
Shkurnikov, M. Y., Нечаев, И. Н., Khaustova, N. A., Krainova, N. A., Савелов, Н. А., Гриневич, В. Н., & Saribekyan, E. K. (2013) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-013-2221-2 · Cited by 6
Renne, M., Conforti, F. S., Camastra, C., Donato, A., & Donato, G. (2014) · European Journal of Inflammation · doi:10.1177/1721727x1401200120 · Cited by 6
Ji, L., Ma, J., & Zhang, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.929870 · Cited by 5
Huang, Q., Mo, J., Yang, H., Ji, Y., Huang, R. H., Liu, Y., & You, P. (2023) · BMC Cancer · doi:10.1186/s12885-023-11012-z · Cited by 5
Immunotherapies in breast cancer: harnessing the cancer immunity cycle
Lok, V. M., Olson-Mcpeek, S. K., Spiegelhoff, G., Cortez, J., Detz, D., & Czerniecki, B. J. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2427038 · Cited by 4
Teng, Q., Yang, X., Wen, S., Zhi-hong, D., Wang, H., Liu, T., Wang, L., Fan, B., & Liu, Z. (2022) · Asian Journal of Andrology · doi:10.4103/aja202186 · Cited by 4
Chondrosarcoma Co-Culture 3D Model─An Insight to Evaluate Drugs Acting on TAMs
Quoniou, R., Moreau, E., Cachin, F., Blavignac, C., Bortoli, E., Chautard, E., & Peyrode, C. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c00625 · Cited by 4
Chen, F., & Fang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.824166 · Cited by 4
3D Coculture between Cancer Cells and Macrophages: From Conception to Experimentation
Quoniou, R., Moreau, E., Cachin, F., Miot-Noirault, E., Chautard, E., & Peyrode, C. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01437 · Cited by 4
Yan, Y., Zhang, R., Zhang, Y., Zhang, X., Zhang, A., & Bu, X. (2020) · Translational Cancer Research · doi:10.21037/tcr-19-2320 · Cited by 4
Obeagu, E. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003500 · Cited by 3
Xiang, L., Rao, Q., He, B., Guo, X., Xu, Y., Luo, B., Zhao, G., & Wu, F. (2023) · Current Medical Science · doi:10.1007/s11596-023-2762-1 · Cited by 3
M2 macrophages do not fly into a “RAGE”
Armando Rojas, R., Añazco, C. C., & Araya, P. (2016) · Inflammation Research · doi:10.1007/s00011-016-0994-2 · Cited by 3
Zhang, P., Jin, Y., Zhang, Q., Yi-ming, W., Wu, W., Yao, W., Wu, Y., Li, Z., Zhao, Y. X., Liu, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.12.4871 · Cited by 3
Li, L., Chen, R., Lin, Y., Humayun, A., Fornace, A. J., & Li, H. (2020) · Advances in Radiation Oncology · doi:10.1016/j.adro.2020.10.014 · Cited by 3
Tumor-associated macrophages-induced lncRNA RP11-627G18.1 promotes breast cancer metastasis
Hong, L., Huang, Y.-J., Ye, F., Wang, S., Wang, Y., Luo, J., Zhou, Z., Wang, J., Yuan, X., & Zhou, N. (2025) · Genes and Immunity · doi:10.1038/s41435-025-00339-1 · Cited by 2
Ferreira, T., Dias, F., Gama, A., Mano, J. F., Oliveira, P. A., & Medeiros, R. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105184 · Cited by 2
Ilgın, C., Çomut, E., Sarıgül, Ç., Korkmaz, S., Vardar, E., & Muftuoglu, S. F. (2020) · PubMed · doi:10.14670/hh-18-139 · Cited by 2
Cui, A., Xue, Y., Wang, X., Huang, Y., Han, X., Li, X., Niu, D., Niu, S., Zhao, Y., Yang, X., et al. (2020) · Bioscience Reports · doi:10.1042/bsr20201140 · Cited by 2
Targeting adipocyte–immune cell crosstalk to control breast cancer progression
Wang, W., Chen, H., Yin, S., Yang, Z., & Zhang, F. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04685-3 · Cited by 2
Shi, J., Pan, L., Ma, F., Zhang, G., & Duan, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1438091 · Cited by 2
Tumor associated macrophages: current research and perspectives of clinical use
Gratchev, A. N., Samoilova, D. V., Рашидова, М. А., Petrenko, A. A., & Kovaleva, O. V. (2019) · Advances in molecular oncology · doi:10.17650/2313-805x-2018-5-4-20-28 · Cited by 4
Jamiyan, T., Kuroda, H., Hayashi, M., Abe, A., Shimizu, K., & Imai, Y. (2020) · Human Pathology Case Reports · doi:10.1016/j.ehpc.2020.200383 · Cited by 2
Wu, Y., Zhang, C., Zou, L., Chen, Y., Xiao, X., Jiang, Y., & Yang, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1470440/v1 · Cited by 2
Quoniou, R., Bortoli, E., Moreau, E., Cachin, F., Chautard, E., & Peyrode, C. (2025) · Medical Oncology · doi:10.1007/s12032-025-03038-z · Cited by 1
Overcoming therapeutic resistance in oncology: The prospects of inorganic nanotheranostics
Zhang, W., Ma, J., Yanagi, Y., Yin, P., Cheng, J., Wang, Y., Hong, N., Ricke, J., Xue, H., & Cheng, S. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101361 · Cited by 1
Macrophage Quantification in Different Breast Tumor Compartments
(2014) · Jurnalul de Chirurgie · doi:10.7438/1584-9341-10-1-8 · Cited by 1
The efficacy of salivary biomarkers versus serum biomarkers in diagnosis of breast carcinoma
Tarek, H. E., Ellithy, M. M., Morsy, R. A. A., El-Lebedy, D. H., Abbas, R. M., & Shalash, H. N. (2022) · Journal of The Arab Society for Medical Research · doi:10.4103/jasmr.jasmr_16_22 · Cited by 1
Immunopathology and Immunotherapy for Breast Cancer
Ghaffari, N., Razi, S., Keshavarz‐Fathi, M., & Rezaei, N. (2020) · Springer eBooks · doi:10.1007/978-3-030-57949-4_21 · Cited by 1
Jajosky, A. N. (2014) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.5874 · Cited by 1
Desenvolvimento de modelo experimental murino para o estudo da imunobiologia do melanoma.
Cabral, P. C. (2016) · doi:10.11606/d.42.2016.tde-16112016-093857 · Cited by 1
Bravaccini, S., & Maltoni, R. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1134-z · Cited by 1
Zheng, J., & Zhang, B. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01527-x · Cited by 1
The role of obesity in macrophage-mediated mechanisms promoting early-onset colon cancer.
Scheurlen, K. M. (2022) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3850 · Cited by 2
Adipocyte-Induced Inflammation In Prostate Tumor Progression In Bone: Role Of Cxcr2 And Osteopontin
Hardaway, A. (2015) · Human Biology
Macrophages as biomarkers in BCG treatment response in bladder cancer
Oliveira, D. S. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
VDR Status Arbitrates the Prometastatic Effects of Tumor
Zhang, Y., Guo, Q., Zhang, Z., Bai, N., Liu, Z., Xiong, M., Wei, Y., Xiang, R., & Tan, X. (2014)
THE STROMAL ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA IN BREAST TUMOURIGENESIS
Skelhorne‐Gross, G. (2014) · QSpace (Queen's University Library)
Targeting and inhibition of tumor-associated macrophages in breast cancer
Binnemars‐Postma, K. (2017) · doi:10.3990/1.9789036544627
Immune biomarkers in breast cancer pathology specimens : characterization and clinical implications
Burugu, S. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0379406
High grade breast ductal carcinomas have high density of tumor-associated macrophages
Abbasi, A., Rahimi, S., Mahmoudzadeh, L., & Mojdeganlou, H. (2021) · Experimental Oncology · doi:10.32471/exp-oncology.2312-8852.vol-43-no-4.16898
Improving immunotherapy for high grade glioma
Hunn, M. K. (2015) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17013347
Improving immunotherapy for high grade glioma
Hunn, M. K. (2015) · doi:10.26686/wgtn.17013347.v1
Features of the endometrial microenvironment in developing of endometrioid adenocarcinoma
Djordjoliani, P., Bokhua, Z., & Burkadze, G. (2022) · GEORGIAN SCIENTISTS · doi:10.52340/gs.2022.04.02.03
Handayani, M. K., Maulani, H., & Apriyani, N. (2020) · Majalah Patologi Indonesia · doi:10.55816/mpi.v29i2.417
Miao, K., & Liu, X. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v66i.12010
Zhang, X., Peng, C. Y., Xiong, X., & Lian, J. (2024) · Discover Oncology · doi:10.1007/s12672-024-01397-z
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26663005
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26663011
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26662996
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26663014
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26662993
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26663017
Luo, X.-Y., Wu, K.-M., & He, X.-X. (2021) · Figshare · doi:10.6084/m9.figshare.14615275
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26662999
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26663002
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26663008
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26662990
Oncogenèse épithéliale mammaire et cytomégalovirus à « haut » et «faible » risque de transformation
Nehme, Z. (2021) · theses.fr (ABES) · doi:10.70675/fef3d277zc0ebz48e3za619za8b7c47d8350
Mishra, P., Panda, P. L., Das, P. P., Mohanty, L., & Das, B. M. (2026) · National Journal of Medical Research · doi:10.55489/njmr.160320261276
Rosolem, M. C. (2013) · Americanae (AECID Library)
Metadata
- Authors
- Tang, X.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Tang, Xiaoqiang
- ORCID
- Tang, Xiaoqiang
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 332
- Issue
- 1
- Pages
- 3-10
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2077731584
- Cited by
- 276
- References
- 92
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 24 · 2023: 20 · 2022: 21 · 2021: 20 · 2020: 30 · 2019: 24 · 2018: 21 · 2017: 26 · 2016: 16 · 2015: 24 · 2014: 27 · 2013: 9
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tsinghua University
- West China Hospital, Sichuan University
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor-associated macrophages, breast cancer, tumor microenvironment, M2 macrophages, CD68, prognostic factors, diagnostic biomarkers, CD163, vascular endothelial growth factor, hypoxia-inducible factor, PCNA, ferritin light chain, CCL18, TAM infiltration
- MeSH terms
- CD68 Molecule, Animals, Biopsy, Breast Neoplasms, Female, Humans, Macrophages, Predictive Value of Tests, Prognosis, Biomarkers, Tumor, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review